Why Women Are More Susceptible to Alzheimer’s Disease

Alzheimer’s disease disproportionately affects women, with almost two-thirds of those over 65 living with the condition being female. While longer lifespans contribute to this disparity, a growing body of research reveals a complex interplay of biological, genetic, and social factors that increase women’s risk. Understanding these factors is crucial for developing targeted prevention and treatment strategies.

The Role of Longevity

Women, on average, live longer than men – approximately five years longer, with a life expectancy of 83.2 years compared to 78.5 years for men in Germany as of 2022/2024 ¹. Age is the most significant risk factor for Alzheimer’s disease; the older an individual, the higher their likelihood of developing the condition. The incidence of Alzheimer’s increases dramatically with age: 4 out of 1,000 people ages 65 to 74, 32 out of 1,000 ages 75 to 84, and 76 out of 1,000 ages 85 and older ¹.

Beyond Lifespan: Increased Incidence in Women

Even when accounting for longevity, women exhibit a higher incidence of Alzheimer’s disease. Studies indicate that women are approximately 60% more likely to be diagnosed with the disease than men in the same age groups ¹. This suggests that factors beyond lifespan are at play.

Genetic Predisposition: The APOE Gene

The APOE gene is a crucial factor in Alzheimer’s risk, potentially influencing up to 70-90% of cases ². The gene has three common variants: E2, E3, and E4. Carrying one or two E4 variants significantly increases risk, while the E2 variant appears protective ². Importantly, the APOE4 variant increases Alzheimer’s risk more significantly in women than in men, potentially due to hormonal influences ².

Hormonal Influences and Menopause

Hormonal changes, particularly those occurring during menopause, are increasingly recognized as a critical period impacting Alzheimer’s risk. As estradiol levels decline during menopause, the expression of the APOE gene changes, potentially leading to increased protein production ⁴. Research suggests that hormone therapy, initiated soon after menopause, may offer a targeted strategy to mitigate this risk, although further studies are needed ⁴. Early menopause (before age 45) is also associated with an unfavorable risk profile, though the effect is not substantial ¹.

The Glymphatic System and Sleep Disruption

The glymphatic system, the brain’s waste clearance pathway, is crucial for removing amyloid and tau proteins associated with Alzheimer’s disease. This system is most active during deep sleep. Menopause often brings significant sleep disturbances, potentially disrupting the glymphatic system and increasing Alzheimer’s risk. Hormone therapy can improve sleep, potentially mitigating this effect ².

Other Contributing Factors

Several other factors contribute to the increased risk in women, including:

• Lower Education Levels: Historically, women have had less access to education, which is linked to lower income, reduced access to healthcare, and increased risk ².
• Lifestyle Factors: Factors like smoking, obesity, lack of exercise, and social isolation increase dementia risk and may disproportionately affect women.
• Inflammation: Research is exploring differences in brain inflammation between men and women, with a focus on the role of microglia (immune cells in the brain) ².

Future Directions

Researchers are actively investigating the complex interplay of these factors to develop targeted prevention and treatment strategies. Ongoing studies are leveraging AI and large datasets of biological information to better understand the heterogeneity of Alzheimer’s disease and identify sex-specific differences ². While a cure remains distant, a deeper understanding of the unique vulnerabilities of women will pave the way for more effective interventions.